Press Сentre
Наши новости
From September 11 to 15, the VI International Forum of Oncology and Radiotherapy “FOR LIFE” took place in Moscow. The event was supported by the Ministry of Health of the Russian Federation, the Ministry of Science and Higher Education of the Russian Federation, the Russian Academy of Sciences and leading scientific, medical, educational ...
18.09.2023
Chairman of the Board of Directors of the ChemRar Group Andrey Ivashchenko took part in the business program of the Biotechmed-2023 forum, where, at various sites, together with key industry leaders and top officials of federal and regional authorities, state corporations, development institutions, academic institutes and universities of Russia ...
18.09.2023
On July 31, 2023, as part of the design and educational intensive “Archipelag 2023” at the “Chelovek+” site, a meeting of the updated composition of the expert group “Business Climate Transformations” was held in the direction of “New types of entrepreneurial activities based on the introduction of advanced technologies” ( TDK NTI ) . The ...
01.08.2023
From July 27 to 28, the Economic and Humanitarian Forum took place in Saint Petersburg as part of the Second Russia–Africa Summit. ChemRar Group’s representatives led by Irina Yuryevna Tyrnova, Member of the Board of Directors and Head of Exports, took part in the business program of this Forum.
As part of the Forum, a working meeting was held ...
31.07.2023
Avineiro company of the ChemRar Group announces that it has received a registration certificate from the Russian Ministry of Health for the drug AVIANDR® for the treatment of anxiety disorders. The drug was developed with the support of the Russian Ministry of Industry and Trade and within the framework of the NTI Neuronet roadmap. The full ...
10.07.2023
Elpida, the Russian developer of ELPIDA®, an innovative eslulfavarinin-based drug against HIV, has reduced the price for this medicinal product by 15 %. This discount will help the Russian healthcare system provide therapy to a larger number of HIV-infected patients throughout the country without excessive costs.
The end-to-end production cycle ...
22.06.2023
Recently, the Government of the Russian Federation approved the Concept of Technological Development until 2030, developed on behalf of Russian President V.V. Putin. The implementation of the Concept should solve the issues of production of high-tech products in the country. It formulates the main directions necessary to achieve technological ...
06.06.2023
Avineuro, a participant of the NeuroNet National Technology Initiative, has completed clinical trials of AVIANDRⓇ, an anti-anxiety medicine. This medicinal product will help people suffering from generalized anxiety disorder or neurological complications of COVID-19. Andrey Ivashchenko, the leader of the NeuroNet working group, gave a speech about ...
29.05.2023
On May 23, a meeting of the Medicinal Chemistry Scientific Council of the Russian Academy of Sciences was held at the Presidium of the Russian Academy of Sciences, chaired by Academician. S.O. Bachurin, where a number of issues related to the development of research in the field of drug development in academic and university centers of Russia were ...
24.05.2023
On April 29 to May 6, representatives of ChemRar Group visited Morocco. The delegation took part in “Medical Expo 2023”, the largest pharmaceutical exhibition in Morocco, to conduct negotiations with representatives of the Ministry of Health of Morocco and the Association of Pharmaceutical Manufacturers. The parties discussed in detail the ...
07.05.2023
On April 26 to 28, the Invest Ethiopia 2023 forum in Addis Ababa was held to attract foreign direct investments to Ethiopia and improve the country's trade and economic relations with foreign states.
Mr. Ahmed Shide, Minister of Finance of Ethiopia, is giving a speech at the Forum
Representatives of ChemRar Group, who visited the Forum, ...
29.04.2023
API-Technology, a part of ChemRar Group, is launching a project to scale up the production of active pharmaceutical ingredients, assist in import substitution and support technological sovereignty of Russia in the field of pharmaceuticals.
Today, when the Russian pharmaceutical industry faces supply chain issues and problems with the purchase of ...
24.04.2023
Публикации в печатных и электронных СМИ
Видео
Фото
